OT: Nerds chatting [Bioanalytics]

posted by nobody – 2019-03-28 11:14  – Posting: # 20101
Views: 1,909

...and even worse (re Danish footer)

The FDA ordered AbbVie to stop recruiting multiple myeloma patients for a Phase III trial of its anti-cancer drug Venclexta/Venclyxto.

Forty-one out of 194 patients taking AbbVie’s Venclexta (venetoclax) in the company’s trial have died, the FDA found, nearly twice the percent of the patients in the trial’s placebo arm.

Kindest regards, nobody

Complete thread:

Activity
 Admin contact
20,249 posts in 4,261 threads, 1,397 registered users;
online 11 (0 registered, 11 guests [including 7 identified bots]).
Forum time (Europe/Vienna): 22:15 CET

To call the statistician after the experiment is done
may be no more than asking him to perform a postmortem examination:
he may be able to say what the experiment died of.    R.A. Fisher

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5